Akebia Therapeutics logo

Akebia Therapeutics

AKBANASDAQ

Akebia Therapeutics is a biotechnology company in the healthcare sector on NASDAQ, led by John Butler, with a market cap of $440.5M. As of Q3 2025, 47% of shares are held by 175 institutional investors, with BlackRock, Inc. as the largest holder at 7.09%.

President and Chief Executive OfficerJohn Butler
Market Cap$440.5M
Biotechnology
Healthcare
Employees167.0
Websiteakebia.com
Country
United States of America

Overview

Overview of institutional ownership in AKBA as of Q3 2025 with a market cap of $723.8M

All Institutions

Institutions
175
Value Held
$337.6M
Shares Held
123.7M
Avg Position
$1.9M
Median Position
$161.1K

Hedge Funds

Hedge Funds
23
Value Held
$50.3M
Shares Held
18.4M
Avg Position
$2.2M
Median Position
$578.1K

Ownership Breakdown

Institutional (non-HF): 39.69%Institutional (non-HF)Hedge Funds: 6.95%Retail & Other: 53.36%Retail & Other
Institutional (non-HF)
39.69%
$287.3M
Hedge Funds
6.95%
$50.3M
Retail & Other
53.36%
$386.2M

Based on market cap of $723.8M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in AKBA as of Q3 2025

InstitutionPosition Value
B
BlackRock, Inc.
Institution
$51.3M
0.00% of portfolio
$42.4M
0.00% of portfolio
$32.3M
0.00% of portfolio
$16.9M
0.00% of portfolio
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$11.8M
0.00% of portfolio
$10.8M
0.01% of portfolio
UBS Group AG logo
UBS Group AG
Institution
$10.0M
0.00% of portfolio
$8.8M
0.01% of portfolio
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$8.7M
0.01% of portfolio
$7.9M
1.29% of portfolio

Net Capital Flow

Institutional buying and selling activity for AKBA in Q3 2025

Traded
+$37.7M
Buyers
104
Sellers
57
Total Bought
+$75.4M
Total Sold
$37.7M
Avg Position
$1.7M

Biggest Buyers

InstitutionNet Bought
+$10.5M
+3.8M shares
UBS Group AG logo
UBS Group AG
Institution
+$8.2M
+3.0M shares
Invesco Ltd. logo
Invesco Ltd.
ETF Provider
+$5.5M
+2.0M shares
CITIGROUP INC logo
CITIGROUP INC
Institution
+$4.9M
+1.8M shares
+$4.1M
+1.5M shares
+$3.9M
+1.4M shares
+$2.6M
+936.0K shares
+$2.4M
+884.6K shares
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
+$2.4M
+868.5K shares
+$2.2M
+797.8K shares

Biggest Sellers

InstitutionNet Sold
$7.2M
2.0M shares
$5.9M
2.2M shares
EAM Investors, LLC logo
EAM Investors, LLC
Long Only Manager
$5.3M
1.5M shares
Woodline Partners LP logo
Woodline Partners LP
Hedge FundLong/Short
$3.6M
1.0M shares
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$2.8M
1.0M shares
$1.8M
658.6K shares
$1.5M
542.6K shares
N
Nuveen, LLC
Institution
$1.1M
407.3K shares
ExodusPoint Capital Management, LP logo
ExodusPoint Capital Management, LP
Hedge FundMulti-Strategy
$1.1M
289.5K shares
$816.3K
299.0K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited AKBA in Q3 2025

New Positions
15
New Value
$2.4M
Exited Positions
18
Exited Value
$19.6M

New Positions

InstitutionPosition Value
$578.1K
211.8K shares
F
Freestone Grove Partners LP
Hedge FundMulti-Strategy
$551.8K
202.1K shares
$426.9K
143.2K shares
$191.1K
70.0K shares
$149.6K
54.8K shares
$137.1K
50.2K shares
S
$77.5K
28.4K shares
$72.7K
26.6K shares
$54.6K
20.0K shares
$54.1K
19.8K shares

Exited Positions

InstitutionPrevious Position
$7.2M
2.0M shares
EAM Investors, LLC logo
EAM Investors, LLC
Long Only Manager
$5.3M
1.5M shares
Woodline Partners LP logo
Woodline Partners LP
Hedge FundLong/Short
$3.6M
1.0M shares
ExodusPoint Capital Management, LP logo
ExodusPoint Capital Management, LP
Hedge FundMulti-Strategy
$1.1M
289.5K shares
$697.8K
191.7K shares
$614.2K
168.7K shares
Point72 Asset Management, L.P. logo
Point72 Asset Management, L.P.
Hedge FundMulti-Strategy
$341.1K
93.7K shares
F
FRED ALGER MANAGEMENT INC
Long Only Manager
$243.9K
67.0K shares
Y
Y-Intercept Ltd
Institution
$111.6K
30.7K shares
H
$104.5K
28.3K shares

Options Activity

Institutions with the largest Call and Put options positions in AKBA as of Q3 2025

Call Positions
3
Call Value
$729.5K
Put Positions
2
Put Value
$765.5K

Call Positions

InstitutionPosition Value
$329.2K
1.2K contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$288.6K
1.1K contracts
$111.7K
409.0 contracts

Put Positions

InstitutionPosition Value
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$628.4K
2.3K contracts
$137.0K
502.0 contracts

Most Committed Institutions

Institutions with AKBA as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
1.29%
$7.9M
Affinity Asset Advisors, LLC logo
Affinity Asset Advisors, LLC
Hedge FundLong/Short
0.68%
$6.7M
N
Nantahala Capital Management, LLC
Hedge FundMulti-Strategy
0.34%
$5.5M
0.19%
$146.1K
Diametric Capital, LP logo
Diametric Capital, LP
Hedge FundLong/Short
0.09%
$239.2K
0.07%
$426.9K
0.05%
$49.1K
E
EntryPoint Capital, LLC
Hedge FundLong/Short
0.05%
$121.4K
GSA CAPITAL PARTNERS LLP logo
GSA CAPITAL PARTNERS LLP
Hedge FundQuant
0.04%
$498.1K
S
0.04%
$77.5K

Hedge Fund Spotlight

Discover hedge funds investing in AKBA

PANAGORA ASSET MANAGEMENT INC logo
PANAGORA ASSET MANAGEMENT INC
Hedge FundQuant
Portfolio ManagerBryan David Belton
Portfolio Value
$24.8B
Positions
1,146
Last Reported
Q3 2025
AddressBoston, MA
Sector Allocation
Technology: 35.30%TechnologyFinancial Services: 13.20%Financial ServicesConsumer Cyclical: 9.30%Consumer CyclicalCommunication Services: 9.10%Communication ServicesHealthcare: 8.80%HealthcareIndustrials: 8.40%IndustrialsConsumer Defensive: 4.20%Utilities: 3.00%Basic Materials: 2.40%Energy: 2.40%Real Estate: 1.90%ETF: 0.70%
Akebia Therapeutics logo

Position in Akebia Therapeutics

Market Value
$644.7K
Shares Held
236.2K
Portfolio Weight
0.00%
Owned Since
2025-Q2
Top HoldingSectorMarket ValueWeight
1
Nvidia logo
Nvidia
NVDA
Semiconductors
Technology
$1.9B7.75%
2
Apple logo
Apple
AAPL
Consumer Electronics
Technology
$1.4B5.65%
Software - Infrastructure
Technology
$1.4B5.45%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.